NCT06791603 The Impact of Social Media-delivered Chemotherapy Side Effects Education for Breast Cancer Patients Receiving Chemotherapy
| NCT ID | NCT06791603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Medical University Shuang Ho Hospital |
| Condition | Chemotherapy Side Effects |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-06 |
| Primary Completion | 2025-12-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The goal of this clinical trial is to learn if a standardized pharmacists-provided education module by social media can improve patients' knowledge of chemotherapy-related side effects. The main questions it aims to answer is: • Do patients who received a standardized pharmacists-provided education module by social media improve their knowledge of chemotherapy-related side effects? Researchers will compare standardized chemotherapy education +video (experimental group) versus chemotherapy handouts (control group). Participants will: * Received standardized chemotherapy education + video or chemotherapy handouts at the first and second chemotherapy section. * Fill out a questionnaire for outcomes assessment.
Eligibility Criteria
Inclusion Criteria: * Breast cancer patients aged 18 or older undergoing their first chemotherapy. * Possess a smartphone and are able to watch videos on it. Exclusion Criteria: * Unable to read or complete questionnaires in Chinese. * Cognitive impairments. * Pregnant women.